drugset / Trial / NCT05495425
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of NPC-12Y gel compared with placebo for skin lesions associated with tuberous sclerosis.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2024-10-30
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 0.2 % | Topical |